
Reset all filters
01 1GlaxoSmithKline Inc.
Reset all filters
01 13041684
Reset all filters
01 1DOSTARLIMAB
Reset all filters
01 1SOLUTION
Reset all filters
01 12037-11-01
Patent Expiration Date : 2037-11-01
Date Granted : 2023-09-26
Brand Name : JEMPERLI
Patent Number : 3041684
Filing Date : 2017-11-01
Strength per Unit : 50mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2037-11-01
Date Granted : 2023-09-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF